DWF Labs related wallet withdrew 96.2 million 1CAT from CEX three hours ago

US Dollar Index rises for 5 consecutive days

Johnson & Johnson announced that its Tecvayli® combined with Darzalex Faspro® treatment regimen has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory multiple myeloma patients.

U.S. federal banking regulators clarify capital treatment rules for tokenized securities

Tevogen Bio Holdings (Tevogen) has recently taken a key step in its generic drug business strategy, signing a letter of intent to officially begin evaluating the potential acquisition of Apozeal Pharmaceuticals.